Everest Medicines Ltd. is a biopharmaceutical company, which engages in the discovering, developing, manufacturing, and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asian markets. The company is headquartered in Shanghai, Shanghai and currently employs 722 full-time employees. The company went IPO on 2020-10-09. The firm has built a product pipeline across renal, anti-infective, and autoimmune diseases. The Company’s products portfolio includes Nefecon (TARPEYO) using in the renal therapeutic area, XERAVA (eravacycline) using in the treatment of infections caused by susceptible gram-positive, gram-negative and anaerobic pathogens including those multidrug resistant isolates and other products. The firm conducts its business in the domestic and overseas markets.
01952.HK stock price ended at $38.24 on jeudi, after dropping 2.85%
On the latest trading day Feb 12, 2026, the stock price of 01952.HK fell by 2.85%, dropping from $39.36 to $38.24. During the session, the stock saw a volatility of 4.03%, with prices oscillating between a daily low of $38.22 and a high of $39.76. On the latest trading day, the trading volume for 01952.HK rose by 37.1K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 1.5M shares were traded, with a market value of approximately $13.5B.
Signaux Techniques de 01952.HK
Résumé des Signaux Techniques
Acheter des signaux 2
Signaux neutres 2
Signaux de vente 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
01952.HK présente actuellement 2 signaux d'achat et 3 signaux de vente. L'action est en Tendance baissière depuis 12:00 AM, avec une variation totale du prix de -3.14% pendant cette période. En général, les indicateurs techniques indiquent une tendance Sell à moyen terme.
Signaux haussiers/baissiers pour 01952.HK
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour 01952.HK, vous aidant à prendre des décisions d'investissement éclairées.